european society for clinical and economic aspects of osteoporosis and osteoarthritis

It is a not-for-profit organization, dedicated to a close interaction between clinical scientists dealing with bone, joint and muscle disorder, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of Osteoporosis and Osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception.Jean-Yves Reginster is the President and Vice President is John A. KANIS. The world's leading clinical conference on bone, joint and muscle health are conducted by ESCEO. These conferences give an insight into cutting edge of Bone Health, challenge faced in osteoporosis diagnosis and treatment. ESCEO also reviews the various aspects of health technology assessment in osteoporosis, including epidemiology and burden of disease, and assessment of the cost-effectiveness of recent advances in the treatment of osteoporosis and the prevention of fracture, in the context of the allocation of health-care resources by decision makers in osteoporosis. ESCEO brings together physicians, subject experts and researchers at a place and help them exchange valuable information.